Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaccinia immune globulin for mpox or smallpox
jRCTs031220744Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Sep 2023
- Modality
- IgG Antibodies → Naked Antibodies → Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of Human vaccinia virus immune globulin in mpox and smallpox, sponsored by Japan Agency for Medical Research and Development. Started Sep 2023; status: completed.
02
Drugs
Human vaccinia virus immune globulin
03
Conditions
mpoxsmallpox
Beyond the preview
Go deeper on jRCTs031220744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220744.